Observational analysis identifies ACSM3 as a tumor suppressor in breast cancer, suggesting its potential as a therapeutic target.
ACSM3 functions as a tumor suppressor in breast cancer by regulating the WNT/AKT signaling pathway, thereby inhibiting cell proliferation, migration, and invasion. These results suggest that ACSM3 may serve as a potential therapeutic target for breast cancer treatment.
No takes yet. Share an insight, caveat, or question.
Hong-Beum Kim (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: